Is There a Lower Limit of Pretreatment Pulmonary Function for Safe and Effective Stereotactic Body Radiotherapy for Early-Stage Non-small Cell Lung Cancer?-Reference-Cited by-同舟云学术

Is There a Lower Limit of Pretreatment Pulmonary Function for Safe and Effective Stereotactic Body Radiotherapy for Early-Stage Non-small Cell Lung Cancer?

Published:2012-03 Issue:3 Volume:7 Page:542-551
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Guckenberger Matthias,Kestin Larry L.,Hope Andrew J.,Belderbos Jose,Werner-Wasik Maria,Yan Di,Sonke Jan-Jakob,Bissonnette Jean Pierre,Wilbert Juergen,Xiao Ying,Grills Inga S.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference37 articles.

1. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy;Baumann;J Clin Oncol,2009

2. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study;Fakiris;Int J Radiat Oncol Biol Phys,2009

3. Prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: results of a Phase II trial;Bral;Int J Radiat Oncol Biol Phys,2011

4. Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial;Ricardi;Lung Cancer,2010

5. Stereotactic body radiation therapy for inoperable early stage lung cancer;Timmerman;JAMA,2010

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereotactic ablative radiotherapy (SABR) for patients with lung tumor and severe pulmonary function impairment;Clinical and Translational Oncology;2024-06-13

2. Optimizing lung cancer radiation therapy: A systematic review of multifactorial risk assessment for radiation-induced lung toxicity;Cancer Treatment Reviews;2024-03

3. SABR for Early Non-Small Cell Lung Cancer: Changes in Pulmonary Function, Dyspnea, and Quality of Life;International Journal of Radiation Oncology*Biology*Physics;2023-12

4. Stereotactic radiotherapy for ultracentral lung tumours;Cancer/Radiothérapie;2023-09

5. ITC-6102RO, a novel B7-H3 antibody-drug conjugate, exhibits potent therapeutic effects against B7-H3 expressing solid tumors;Cancer Cell International;2023-08-18